Skip to main content

Table 2 Information of patients' ovarian stimulation cycle and its results

From: Controlled ovarian stimulation in cancer patients under 18 years old; a case series

Case

1

2

3

4

5

6

7

8

9

10

COS Protocol

GnRH antagonist

Stimulation cycle start

Early. Pb

Luteal Phasec

Early. Pd

Late. Pe

Early. P

Gonadotropins

recombinant-FSH

Starting gonadotropin dose (IU)

150

225

150

150

150

150

150

112.5

150

150

Total gonadotropin dose (IU)

1050

2025

1350

1500

1200

1650

1425

1687.5

1350

1350

GnRH-antagonist (ampule)

4

4

5

6

4

8

3

9

6

5

Duration of stimulation (day)

8

10

10

11

9

12

9

14

10

11

Follicle> 12 mma

10

6

12

11

13

17

11

13

8

22

Triggering medication

2recombinant-HCG

Low dose GnRH-agonist

Total oocytes retrieved

13

10

9

10

21

6

8

0

32

33

Total mature oocytes (MII)

13

10

9

8

17

5

5

0

26

23

Total oocytes cryopreservation

13

5

9

8

20f

0

7f

0

26

23

Total embryos cryopreservation

-

5

-

-

-

5

-

-

-

-

OHSS & others side effects

No

  1. aIn the day of triggering final oocyte maturation
  2. bProliferative
  3. cProgesterone >1.5 ng/ml
  4. dLarges follicle <13 mm & progesterone <1.5 ng/ml
  5. eLarges follicle >13 mm & progesterone <1.5 ng/ml
  6. fMII+GV (germinal vesicle)